标普和纳斯达克内在价值 联系我们

Allurion Technologies Inc. ALUR OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
37/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.50
+177.8%

Allurion Technologies Inc. (ALUR) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Natick, MA, 美国. 现任CEO为 Samuel G. Levy.

ALUR 拥有 IPO日期为 2021-03-29, 134 名全职员工, 在 Other OTC, 市值为 $6.79M.

关于 Allurion Technologies Inc.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

📍 11 Huron Drive, Natick, MA 01760 📞 508 647 4000
公司详情
所属板块医疗保健
细分行业Medical - Devices
国家美国
交易所Other OTC
货币USD
IPO日期2021-03-29
首席执行官Samuel G. Levy
员工数134
交易信息
当前价格$0.90
市值$6.79M
52周区间0.23-3.42
Beta-0.42
ETF
ADR
CUSIP02008G102
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言